TR-57

N/A

Report date: 2024/02/06 16:32:15
NME

Base Information

Drug NameTR-57
Drug Alias NameTR-57
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial proteins modulators
TargetsMitochondrial proteins
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMadera Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesMadera Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A